Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-04

Clinical Trial Update: Optimal Sensing in Atrial Tachyarrhythmia's Study [NA]

View source ↗

Summary

Abbott Medical Devices' clinical trial on optimal sensing in atrial tachyarrhythmias has been terminated, involving Sick Sinus Syndrome and Paroxysmal Atrial Fi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Abbott Medical Devices | Conditions: Sick Sinus Syndrome, Paroxysmal Atrial Fibrillation | NA | Status: TERMINATED